As Introduced 1
123rd General Assembly 4
Regular Session H. B. No. 428 5
1999-2000 6
REPRESENTATIVES CALVERT-TAYLOR-WILLAMOWSKI-TERWILLEGER- 8
WILLIAMS-HOLLISTER-GRENDELL-DePIERO-HOUSEHOLDER-HOOPS- 9
BUEHRER-NETZLEY-COUGHLIN-JACOBSON-BATEMAN-JERSE-O'BRIEN- 10
MOTTLEY-CLANCY-CORBIN-FLANNERY-ALLEN-PRINGLE-HOOD-HARTNETT- 11
ROMAN-BENDER 12
_________________________________________________________________ 13
A B I L L
To amend section 3719.41 of the Revised Code to make 15
gamma-hydroxy-butyrate a schedule II controlled 16
substance and to revise the state controlled 17
substances schedules according to federal drug
laws.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO: 19
Section 1. That section 3719.41 of the Revised Code be 21
amended to read as follows: 22
Sec. 3719.41. Controlled substance schedules I, II, III, 31
IV, and V are hereby established, which schedules include the 32
following, subject to amendment pursuant to section 3719.43 or 33
3719.44 of the Revised Code. 34
SCHEDULE I 36
(A) Narcotics-opiates 38
Any of the following opiates, including their isomers, 40
esters, ethers, salts, and salts of isomers, esters, and ethers, 41
unless specifically excepted under federal drug abuse control 42
laws, whenever the existence of these isomers, esters, ethers, 43
and salts is possible within the specific chemical designation: 44
(1) Acetyl-alpha-methylfentanyl 47
(N-[-1[1-(1-methyl-2-phenethyl)-4-piperidinyl<-N-phenylacetamide);
(2) Acetylmethadol; 49
2
(3) Allylprodine; 51
(4) Alphacetylmethadol (except levo-alphacetyl-methadol 53
LEVO-ALPHACETYLMETHADOL, also known as levo-alpha-acetyl-methadol 55
LEVO-ALPHA-ACETYLMETHADOL, levomethadyl acetate, or LAAM); 56
(5) Alphameprodine; 58
(6) Alphamethadol; 60
(7) Alpha-methylfentanyl 63
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl<
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) 64
piperidine); 65
(8) Alpha-methylthiofentanyl 68
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl<-N-
phenylpropanamide); 69
(9) Benzethidine; 71
(10) Betacetylmethadol; 73
(11) Beta-hydroxyfentanyl 76
(N-[1-(2-hydroxy-2-phenethyl-4-piperidinyl<-N-
phenylpropanamide); 77
(12) Beta-hydroxy-3-methylfentanyl (other name: 80
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl<-N-
phenylpropanamide); 81
(13) Betameprodine; 83
(14) Betamethadol; 85
(15) Betaprodine; 87
(16) Clonitazene; 89
(17) Dextromoramide; 91
(18) Diampromide; 93
(19) Diethylthiambutene; 95
(20) Difenoxin; 97
(21) Dimenoxadol; 99
(22) Dimepheptanol; 101
(23) Dimethylthiambutene; 103
(24) Dioxaphetyl butyrate; 105
(25) Dipipanone; 107
3
(26) Ethylmethylthiambutene; 109
(27) Etonitazene; 111
(28) Etoxeridine; 113
(29) Furethidine; 115
(30) Hydroxypethidine; 117
(31) Ketobemidone; 119
(32) Levomoramide; 121
(33) Levophenacylmorphan; 123
(34) 3-methylfentanyl 126
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl<-N-
phenylpropanamide); 127
(35) 3-methylthiofentanyl 130
(N-[3-methyl-1-[2-(thienyl)ethyl<-4-piperidinyl<-N-
phenylpropanamide); 131
(36) Morpheridine; 133
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 135
(38) Noracymethadol; 137
(39) Norlevorphanol; 139
(40) Normethadone; 141
(41) Norpipanone; 143
(42) Para-fluorofentanyl 146
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinylPEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine; 148
(44) Phenadoxone; 150
(45) Phenampromide; 152
(46) Phenomorphan; 154
(47) Phenoperidine; 156
(48) Piritramide; 158
(49) Proheptazine; 160
(50) Properidine; 162
(51) Propiram; 164
(52) Racemoramide; 166
(53) Thiofentanyl 169
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl<-propanamide;
4
(54) Tilidine; 171
(55) Trimeperidine. 173
(B) Narcotics-opium derivatives 175
Any of the following opium derivatives, including their 177
salts, isomers, and salts of isomers, unless specifically 178
excepted under federal drug abuse control laws, whenever the 179
existence of these salts, isomers, and salts of isomers is 180
possible within the specific chemical designation: 181
(1) Acetorphine; 183
(2) Acetyldihydrocodeine; 185
(3) Benzylmorphine; 187
(4) Codeine methylbromide; 189
(5) Codeine-n-oxide; 191
(6) Cyprenorphine; 193
(7) Desomorphine; 195
(8) Dihydromorphine; 197
(9) Drotebanol; 199
(10) Etorphine (except hydrochloride salt); 201
(11) Heroin; 203
(12) Hydromorphinol; 205
(13) Methyldesorphine; 207
(14) Methyldihydromorphine; 209
(15) Morphine methylbromide; 211
(16) Morphine methylsulfonate; 213
(17) Morphine-n-oxide; 215
(18) Myrophine; 217
(19) Nicocodeine; 219
(20) Nicomorphine; 221
(21) Normorphine; 223
(22) Pholcodine; 225
(23) Thebacon. 227
(C) Hallucinogens 229
Any material, compound, mixture, or preparation that 231
contains any quantity of the following hallucinogenic substances, 232
5
including their salts, isomers, and salts of isomers, unless 233
specifically excepted under federal drug abuse control laws, 235
whenever the existence of these salts, isomers, and salts of 236
isomers is possible within the specific chemical designation. 237
For the purposes of this division only, "isomer" includes the 238
optical isomers, position isomers, and geometric isomers. 239
(1) ALPHA-ETHYLTRYPTAMINE (SOME TRADE OR OTHER NAMES: 241
ETRYPTAMINE; MONASE; ALPHA-ETHYL-1H-INDOLE-3-ETHANAMINE; 242
3-(2-AMINOBUTYL) INDOLE; ALPHA-ET; AND AET); 243
(2) 4-bromo-2,5-dimethoxyamphetamine (some trade or other 245
names: 4-bromo-2,5-dimethoxy-alpha-methyphenethylamine; 246
4-bromo-2,5-DMA); 247
(2)(3) 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE (SOME TRADE OR 249
OTHER NAMES: 2-(4-BROMO-2,5-DIMETHOXYPHENYL)-1-AMINOETHANE; 250
ALPHA-DESMETHYL DOB; 2C-B, NEXUS); 251
(4) 2,5-dimethoxyamphetamine (some trade or other names: 253
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); 254
(3)(5) 2,5-dimethoxy-4-ethylamphetamine (some trade or 256
other names: DOET); 257
(4)(6) 4-methoxyamphetamine (some trade or other names: 259
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; 261
PMA);
(5)(7) 5-methoxy-3,4-methylenedioxy-amphetamine; 263
(6)(8) 4-methyl-2,5-dimethoxy-amphetamine (some trade or 265
other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; 266
"DOM" and "STP"); 267
(7)(9) 3,4-methylenedioxy amphetamine; 269
(8)(10) 3,4-methylenedioxymethamphetamine (MDMA); 271
(9)(11) 3,4-methylenedioxy-N-ethylamphetamine (also known 273
as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, 274
N-ethyl MDA, MDE, MDEA); 275
(10)(12) N-hydroxy-3,4-methylenedioxyamphetamine (also 277
known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine 278
and N-hydroxy MDA); 279
6
(11)(13) 3,4,5-trimethoxy amphetamine; 281
(12)(14) Bufotenine (some trade or other names: 283
3-(beta-dimethylaminoethyl)-5-hydroxyindole; 284
3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 285
5-hydroxy-N, N-dimethyltryptamine; mappine); 286
(13)(15) Diethyltryptamine (some trade or other names: N, 288
N-diethyltryptamine; DET); 289
(14)(16) Dimethyltryptamine (some trade or other names: 291
DMT); 292
(15)(17) Ibogaine (some trade or other names: 294
7-ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano- 295
5H-pyrido[1',2':1,2< azepino [5,4-B 4-b< indole; tabernanthe 298
iboga);
(16)(18) Lysergic acid diethylamide; 300
(17)(19) Marihuana; 302
(18)(20) Mescaline; 304
(19)(21) Parahexyl (some trade or other names: 3-hexyl-1- 306
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d(20)(22) Peyote (meaning all parts of the plant presently 310
classified botanically as "Lophophora williamsii Lemaire," 311
whether growing or not, the seeds of that plant, any extract from 312
any part of that plant, and every compound, manufacture, salts, 313
derivative, mixture, or preparation of that plant, its seeds, or 314
its extracts); 315
(21)(23) N-ethyl-3-piperidyl benzilate; 317
(22)(24) N-methyl-3-piperidyl benzilate; 319
(23)(25) Psilocybin; 321
(24)(26) Psilocyn; 323
(25)(27) Tetrahydrocannabinols (synthetic equivalents of 325
the substances contained in the plant, or in the resinous 326
extractives of Cannabis, sp. and/or synthetic substances, 327
derivatives, and their isomers with similar chemical structure 328
and pharmacological activity such as the following: delta-1-cis 329
7
or trans tetrahydrocannabinol, and their optical isomers; 330
delta-6-cis or trans tetrahydrocannabinol, and their optical 331
isomers; delta-3,4-cis or trans tetrahydrocannabinol, and its 332
optical isomers. (Since nomenclature of these substances is not 333
internationally standardized, compounds of these structures, 334
regardless of numerical designation of atomic positions, are 335
covered.)); 336
(26)(28) Ethylamine analog of phencyclidine (some trade or 338
other names: N-ethyl-1-phenylcyclohexylamine; 339
(1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; 340
cyclohexamine; PCE); 341
(27)(29) Pyrrolidine analog of phencyclidine (some trade 343
or other names: 1-(1-phenylcyclohexyl)pyrrolidine; PCPY PCPy; 345
PHP);
(28)(30) Thiophene analog of phencyclidine (some trade or 347
other names: 1-[1-(2-thienyl)-cyclohexyl<-piperidine; 2-thienyl 348
analog of phencyclidine; TPCP; TCP); 349
(29)(31) 1-[1-(2-thienyl)cyclohexyl(30)(32) Hashish. 353
(D) Depressants 355
Any material, compound, mixture, or preparation that 357
contains any quantity of the following substances having a 358
depressant effect on the central nervous system, including their 359
salts, isomers, and salts of isomers, unless specifically 360
excepted under federal drug abuse control laws, whenever the 361
existence of these salts, isomers, and salts of isomers is 362
possible within the specific chemical designation: 363
(1) Mecloqualone; 365
(2) Methaqualone. 367
(E) Stimulants 369
Unless specifically excepted or unless listed in another 371
schedule, any material, compound, mixture, or preparation that 372
contains any quantity of the following substances having a 373
stimulant effect on the central nervous system, including their 374
8
salts, isomers, and salts of isomers: 375
(1) Aminorex (some other names: aminoxaphen; 377
2-amino-5-phenyl-2-oxazoline; or 378
4,5-dihydro-5-phenyl-2-oxazolamine);
(2) Cathinone (SOME TRADE OR OTHER NAMES: 380
2-AMINO-1-PHENYL-1-PROPANONE, ALPHA-AMINOPROPIOPHENONE, 381
2-AMINOPROPIOPHENONE, AND NOREPHEDRONE); 382
(3) Fenethylline; 384
(4) Methcathinone (some other names: 386
2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 387
2-methylamino)-1-phenylpropan-1-one;
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; 388
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and 389
UR1432), its salts, optical isomers, and salts of optical 390
isomers;
(5) (+/-)cis-4-methylaminorex 392
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine); 393
(6) N-ethylamphetamine; 395
(7) N,N-dimethylamphetamine (also known as 397
N,N-alpha-trimethyl-benzeneethanamine; 398
N,N-alpha-trimethylphenethylamine). 399
SCHEDULE II 401
(A) Narcotics-opium and opium derivatives 403
Unless specifically excepted under federal drug abuse 405
control laws or unless listed in another schedule, any of the 406
following substances whether produced directly or indirectly by 407
extraction from substances of vegetable origin, independently by 408
means of chemical synthesis, or by a combination of extraction 409
and chemical synthesis: 410
(1) Opium and opiate, and any salt, compound, derivative, 412
or preparation of opium or opiate, excluding apomorphine, 413
thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, 414
naloxone, and naltrexone, and their respective salts, but 415
including the following: 416
9
(a) Raw opium; 418
(b) Opium extracts; 420
(c) Opium fluid extracts; 422
(d) Powdered opium; 424
(e) Granulated opium; 426
(f) Tincture of opium; 428
(g) Codeine; 430
(h) Ethylmorphine; 432
(i) Etorphine hydrochloride; 434
(j) Hydrocodone; 436
(k) Hydromorphone; 438
(l) Metopon; 440
(m) Morphine; 442
(n) Oxycodone; 444
(o) Oxymorphone; 446
(p) Thebaine. 448
(2) Any salt, compound, derivative, or preparation thereof 450
that is chemically equivalent to or identical with any of the 451
substances referred to in division (A)(1) of this schedule, 452
except that these substances shall not include the isoquinoline 453
alkaloids of opium; 454
(3) Opium poppy and poppy straw; 456
(4) Coca leaves and any salt, compound, derivative, or 458
preparation of coca leaves (including cocaine and ecgonine, their 459
salts, isomers, and derivatives, and salts of those isomers and 460
derivatives), and any salt, compound, derivative, or preparation 461
thereof that is chemically equivalent to or identical with any of 462
these substances, except that the substances shall not include 463
decocainized coca leaves or extraction of coca leaves, which 464
extractions do not contain cocaine or ecgonine; 465
(5) Concentrate of poppy straw (the crude extract of poppy 467
straw in either liquid, solid, or powder form that contains the 468
phenanthrene alkaloids of the opium poppy). 469
(B) Narcotics-opiates 471
10
Unless specifically excepted under federal drug abuse 473
control laws or unless listed in another schedule, any of the 474
following opiates, including their isomers, esters, ethers, 475
salts, and salts of isomers, esters, and ethers, whenever the 476
existence of these isomers, esters, ethers, and salts is possible 477
within the specific chemical designation, but excluding 478
dextrorphan and levopropoxyphene: 479
(1) Alfentanil; 481
(2) Alphaprodine; 483
(3) Anileridine; 485
(4) Bezitramide; 487
(5) Bulk dextropropoxyphene (non-dosage forms); 489
(6) Carfentanil; 491
(7) Dihydrocodeine; 493
(8) Diphenoxylate; 495
(9) Fentanyl; 497
(10) Isomethadone; 499
(11) Levo-alphacetylmethadol (some other names: 501
levo-alpha-acetylmethadol,; levomethadyl acetate; LAAM); 503
(12) Levomethorphan; 505
(13) Levorphanol; 507
(14) Metazocine; 509
(15) Methadone; 511
(16) Methadone-intermediate, 513
4-cyano-2-dimethylamino-4,4-diphenyl butane; 514
(17) Moramide-intermediate, 516
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid; 517
(18) Pethidine (meperidine); 519
(19) Pethidine-intermediate-A, 521
4-cyano-1-methyl-4-phenylpiperidine; 522
(20) Pethidine-intermediate-B, 524
ethyl-4-phenylpiperidine-4-carboxylate; 525
(21) Pethidine-intermediate-C, 527
1-methyl-4-phenylpiperidine-4-carboxylic acid; 528
11
(22) Phenazocine; 530
(23) Piminodine; 532
(24) Racemethorphan; 534
(25) Racemorphan; 536
(26) REMIFENTANIL; 538
(27) Sufentanil. 540
(C) Stimulants 542
Unless specifically excepted under federal drug abuse 544
control laws or unless listed in another schedule, any material, 545
compound, mixture, or preparation that contains any quantity of 546
the following substances having a stimulant effect on the central 547
nervous system: 548
(1) Amphetamine, its salts, its optical isomers, and salts 550
of its optical isomers; 551
(2) Methamphetamine, its salts, its isomers, and salts of 553
its isomers; 554
(3) Methylphenidate; 556
(4) Phenmetrazine and its salts. 558
(D) Depressants 560
Unless specifically excepted under federal drug abuse 562
control laws or unless listed in another schedule, any material, 563
compound, mixture, or preparation that contains any quantity of 564
the following substances having a depressant effect on the 565
central nervous system, including their salts, isomers, and salts 566
of isomers, whenever the existence of these salts, isomers, and 567
salts of isomers is possible within the specific chemical 568
designation: 569
(1) Amobarbital; 571
(2) GAMMA-HYDROXY-BUTYRATE; 573
(3) Glutethimide; 575
(3)(4) PENTOBARBITAL; 577
(5) Phencyclidine (some trade or other names: 579
1-(1-phenylcyclohexyl)piperidine; PCP); 580
(4) Pentobarbital; 582
12
(5)(6) Secobarbital; 584
(6)(7) 1-aminophenylcyclohexane and all N-mono-substituted 586
and/or all N-N-disubstituted analogs, including, but not limited 588
to, the following: 589
(a) 1-phenylcyclohexylamine; 591
(b) (1-phenylcyclohexyl) methylamine; 593
(c) (1-phenylcyclohexyl) dimethylamine; 595
(d) (1-phenylcyclohexyl) methylethylamine; 597
(e) (1-phenylcyclohexyl) isopropylamine; 599
(f) 1-(1-phenylcyclohexyl) morpholine. 601
(E) Hallucinogenic substances 603
(1) Dronabinol (synthetic) in sesame oil and encapsulated 605
in a soft gelatin capsule in a United States food and drug 606
administration approved drug product (some other names for 607
dronabinol: (6aR-trans)-6A,7,8,10a-tetrahydro- 608
6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d 609
(-)-delta-9-(trans)-tetrahydrocannabinol); 610
(2) Nabilone (another name for nabilone: 612
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1- 613
hydroxy-6,6-dimethyl-9H-dibenzo[b,dPCP): 630
(a) 1-phenylcyclohexylamine; 632
(b) 1-piperidinocyclohexanecarbonitrile (PCC). 634
SCHEDULE III 636
13
(A) Stimulants 638
Unless specifically excepted under federal drug abuse 640
control laws or unless listed in another schedule, any material, 641
compound, mixture, or preparation that contains any quantity of 642
the following substances having a stimulant effect on the central 643
nervous system, including their salts, their optical isomers, 644
position isomers, or geometric isomers, and salts of these 645
isomers, whenever the existence of these salts, isomers, and 646
salts of isomers is possible within the specific chemical 647
designation:
(1) All stimulant compounds, mixtures, and preparations 649
included in schedule III pursuant to the federal drug abuse 650
control laws and regulations adopted under those laws; 651
(2) Benzphetamine; 653
(3) Chlorphentermine; 655
(4) Clortermine; 657
(5) Phendimetrazine. 659
(B) Depressants 661
Unless specifically excepted under federal drug abuse 663
control laws or unless listed in another schedule, any material, 664
compound, mixture, or preparation that contains any quantity of 665
the following substances having a depressant effect on the 666
central nervous system: 667
(1) Any compound, mixture, or preparation containing 669
amobarbital, secobarbital, pentobarbital, or any salt of any of 670
these drugs, and one or more other active medicinal ingredients 671
that are not listed in any schedule; 672
(2) Any suppository dosage form containing amobarbital, 674
secobarbital, pentobarbital, or any salt of any of these drugs 675
and approved by the food and drug administration for marketing 676
only as a suppository; 677
(3) Any substance that contains any quantity of a 679
derivative of barbituric acid or any salt of a derivative of 680
barbituric acid; 681
14
(4) Chlorhexadol; 683
(5) KETAMINE, ITS SALTS, ISOMERS, AND SALTS OF ISOMERS 685
(SOME OTHER NAMES FOR KETAMINE: 686
(+/-)-2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-CYCLOHEXANONE);
(6) Lysergic acid; 688
(6)(7) Lysergic acid amide; 690
(7)(8) Methyprylon; 692
(8)(9) Sulfondiethylmethane; 694
(9)(10) Sulfonethylmethane; 696
(10)(11) Sulfonmethane; 698
(11)(12) Tiletamine, zolazepam, or any salt of tiletamine 700
or zolazepam (some trade or other names for a 701
tiletamine-zolazepam combination product: Telazol); (some trade 702
or other names for tiletamine: 703
2-(ethylamino)-2-(2-thienyl)-cyclohexanone); (some trade or other 704
names for zolazepam: 4-(2-fluorophenyl)-6,8-
dihydro-1,3,8-trimethylpyrazolo-[3,4-E 706
4-e<[1,4<-diazepin-7(1H)-one; flupyrazapon). 707
(C) Narcotic antidotes 709
(1) Nalorphine. 711
(D) Narcotics-narcotic preparations 713
Unless specifically excepted under federal drug abuse 715
control laws or unless listed in another schedule, any material, 716
compound, mixture, or preparation that contains any of the 717
following narcotic drugs, or their salts calculated as the free 718
anhydrous base or alkaloid, in limited quantities as set forth 719
below: 720
(1) Not more than 1.8 grams of codeine per 100 milliliters 722
or not more than 90 milligrams per dosage unit, with an equal or 723
greater quantity of an isoquinoline alkaloid of opium; 724
(2) Not more than 1.8 grams of codeine per 100 milliliters 726
or not more than 90 milligrams per dosage unit, with one or more 727
active, nonnarcotic ingredients in recognized therapeutic 728
amounts; 729
15
(3) Not more than 300 milligrams of dihydrocodeinone per 731
100 milliliters or not more than 15 milligrams per dosage unit, 732
with a fourfold or greater quantity of an isoquinoline alkaloid 733
of opium; 734
(4) Not more than 300 milligrams of dihydrocodeinone per 736
100 milliliters or not more than 15 milligrams per dosage unit, 737
with one or more active, nonnarcotic ingredients in recognized 738
therapeutic amounts; 739
(5) Not more than 1.8 grams of dihydrocodeine per 100 741
milliliters or not more than 90 milligrams per dosage unit, with 742
one or more active, nonnarcotic ingredients in recognized 743
therapeutic amounts; 744
(6) Not more than 300 milligrams of ethylmorphine per 100 746
milliliters or not more than 15 milligrams per dosage unit, with 747
one or more active, nonnarcotic ingredients in recognized 748
therapeutic amounts; 749
(7) Not more than 500 milligrams of opium per 100 751
milliliters or per 100 grams or not more than 25 milligrams per 752
dosage unit, with one or more active, nonnarcotic ingredients in 753
recognized therapeutic amounts; 754
(8) Not more than 50 milligrams of morphine per 100 756
milliliters or per 100 grams, with one or more active, 757
nonnarcotic ingredients in recognized therapeutic amounts. 758
(E) Anabolic steroids 760
Unless specifically excepted under federal drug abuse 762
control laws or unless listed in another schedule, any material, 763
compound, mixture, or preparation that contains any quantity of 764
the following substances, including their salts, esters, isomers, 765
and salts of esters and isomers, whenever the existence of these 766
salts, esters, and isomers is possible within the specific 767
chemical designation: 768
(1) Anabolic steroids. Except as otherwise provided in 770
division (E)(1) of schedule III, "anabolic steroids" means any 771
drug or hormonal substance that is chemically and 772
16
pharmacologically related to testosterone (other than estrogens, 773
progestins, and corticosteroids) and that promotes muscle growth. 774
"Anabolic steroids" does not include an anabolic steroid that is 775
expressly intended for administration through implants to cattle 776
or other nonhuman species and that has been approved by the 777
United States secretary of health and human services for that 778
administration, unless a person prescribes, dispenses, or 779
distributes this type of anabolic steroid for human use. 780
"Anabolic steroid" includes, but is not limited to, the 781
following: 782
(a) Boldenone; 784
(b) Chlorotestosterone (4-chlortestosterone); 786
(c) Clostebol; 788
(d) Dehydrochlormethyltestosterone; 790
(e) Dihydrotestosterone (4-dihydrotestosterone); 792
(f) Drostanolone; 794
(g) Ethylestrenol; 796
(h) Fluoxymesterone; 798
(i) Formebulone (formebolone); 800
(j) Mesterolone; 802
(k) Methandienone; 804
(l) Methandranone; 806
(m) Methandriol; 808
(n) Methandrostenolone; 810
(o) Methenolone; 812
(p) Methyltestosterone; 814
(q) Mibolerone; 816
(r) Nandrolone; 818
(s) Norethandrolone; 820
(t) Oxandrolone; 822
(u) Oxymesterone; 824
(v) Oxymetholone; 826
(w) Stanolone; 828
(x) Stanozolol; 830
17
(y) Testolactone; 832
(z) Testosterone; 834
(aa) Trenbolone; 836
(bb) Any salt, ester, isomer, or salt of an ester or 838
isomer of a drug or hormonal substance described or listed in 839
division (E)(1) of schedule III if the salt, ester, or isomer 840
promotes muscle growth. 841
(F) HALLUCINOGENIC SUBSTANCES 843
(1) DRONABINOL (SYNTHETIC) IN SESAME OIL AND ENCAPSULATED 845
IN A SOFT GELATIN CAPSULE IN A UNITED STATES FOOD AND DRUG 846
ADMINISTRATION APPROVED DRUG PRODUCT (SOME OTHER NAMES FOR 847
DRONABINOL: (6aR-TRANS)-6a,7,8,10a-TETRAHYDRO- 850
6,6,9-TRIMETHYL-3-PENTYL-6H-DIBENZO[b,dol, OR 851
(-)-DELTA-9-(TRANS)-TETRAHYDROCANNABINOL). 852
SCHEDULE IV 854
(A) Narcotic drugs 856
Unless specifically excepted by federal drug abuse control 858
laws or unless listed in another schedule, any material, 859
compound, mixture, or preparation that contains any of the 860
following narcotic drugs, or their salts calculated as the free 861
anhydrous base or alkaloid, in limited quantities as set forth 862
below: 863
(1) Not more than one milligram of difenoxin and not less 865
than 25 micrograms of atropine sulfate per dosage unit; 866
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino- 868
1,2-diphenyl-3-methyl-2-propionoxybutane)[final dosage forms<. 869
(B) Depressants 871
Unless specifically excepted under federal drug abuse 873
control laws or unless listed in another schedule, any material, 874
compound, mixture, or preparation that contains any quantity of 875
the following substances, including their salts, isomers, and 876
salts of isomers, whenever the existence of these salts, isomers, 877
and salts of isomers is possible within the specific chemical 878
designation: 879
18
(1) Alprazolam; 881
(2) Barbital; 883
(3) Bromazepam; 885
(4) Camazepam; 887
(5) Chloral betaine; 889
(6) Chloral hydrate; 891
(7) Chlordiazepoxide; 893
(8) Clobazam; 895
(9) Clonazepam; 897
(10) Clorazepate; 899
(11) Clotiazepam; 901
(12) Cloxazolam; 903
(13) Delorazepam; 905
(14) Diazepam; 907
(15) Estazolam; 909
(16) Ethchlorvynol; 911
(17) Ethinamate; 913
(18) Ethyl loflazepate; 915
(19) Fludiazepam; 917
(20) Flunitrazepam; 919
(21) Flurazepam; 921
(22) Halazepam; 923
(23) Haloxazolam; 925
(24) Ketazolam; 927
(25) Loprazolam; 929
(26) Lorazepam; 931
(27) Lormetazepam; 933
(28) Mebutamate; 935
(29) Medazepam; 937
(30) Meprobamate; 939
(31) Methohexital; 941
(32) Methylphenobarbital (mephobarbital); 943
(33) Midazolam; 945
(34) Nimetazepam; 947
19
(35) Nitrazepam; 949
(36) Nordiazepam; 951
(37) Oxazepam; 953
(38) Oxazolam; 955
(39) Paraldehyde; 957
(40) Petrichloral; 959
(41) Phenobarbital; 961
(42) Pinazepam; 963
(43) Prazepam; 965
(44) Quazepam; 967
(45) Temazepam; 969
(46) Tetrazepam; 971
(47) Triazolam; 973
(48) Zolpidem. 975
(C) Fenfluramine 977
Any material, compound, mixture, or preparation that 979
contains any quantity of the following substances, including 980
their salts, their optical isomers, position isomers, or 981
geometric isomers, and salts of these isomers, whenever the 982
existence of these salts, isomers, and salts of isomers is 983
possible within the specific chemical designation: 984
(1) Fenfluramine. 986
(D) Stimulants 988
Unless specifically excepted under federal drug abuse 990
control laws or unless listed in another schedule, any material, 991
compound, mixture, or preparation that contains any quantity of 992
the following substances having a stimulant effect on the central 993
nervous system, including their salts, their optical isomers, 994
position isomers, or geometric isomers, and salts of these 995
isomers, whenever the existence of these salts, isomers, and 996
salts of isomers is possible within the specific chemical 997
designation:
(1) Cathine ((+)-norpseudoephedrine); 999
(2) Diethylpropion; 1,001
20
(3) Fencamfamin; 1,003
(4) Fenproporex; 1,005
(5) Mazindol; 1,007
(6) Mefenorex; 1,009
(7) MODAFINIL; 1,011
(8) Pemoline (including organometallic complexes and 1,013
chelates thereof); 1,014
(8)(9) Phentermine; 1,016
(9)(10) Pipradrol; 1,018
(10)(11) SIBUTRAMINE; 1,020
(12) SPA [(-)-1-dimethylamino-1,2-diphenylethane<. 1,023
(E) Other substances 1,025
Unless specifically excepted under federal drug abuse 1,027
control laws or unless listed in another schedule, any material, 1,028
compound, mixture, or preparation that contains any quantity of 1,029
the following substances, including their salts: 1,030
(1) Pentazocine; 1,032
(2) BUTORPHANOL (INCLUDING ITS OPTICAL ISOMERS). 1,034
SCHEDULE V 1,036
(A) Narcotic drugs 1,038
Unless specifically excepted under federal drug abuse 1,040
control laws or unless listed in another schedule, any material, 1,041
compound, mixture, or preparation that contains any of the 1,042
following narcotic drugs, and their salts, as set forth below: 1,043
(1) Buprenorphine. 1,045
(B) Narcotics-narcotic preparations 1,047
Narcotic drugs containing non-narcotic active medicinal 1,049
ingredients. Any compound, mixture, or preparation that contains 1,050
any of the following narcotic drugs, or their salts calculated as 1,051
the free anhydrous base or alkaloid, in limited quantities as set 1,052
forth below, and that includes one or more nonnarcotic active 1,053
medicinal ingredients in sufficient proportion to confer upon the 1,054
compound, mixture, or preparation valuable medicinal qualities 1,055
other than those possessed by narcotic drugs alone: 1,056
21
(1) Not more than 200 milligrams of codeine per 100 1,058
milliliters or per 100 grams; 1,059
(2) Not more than 100 milligrams of dihydrocodeine per 100 1,061
milliliters or per 100 grams; 1,062
(3) Not more than 100 milligrams of ethylmorphine per 100 1,064
milliliters or per 100 grams; 1,065
(4) Not more than 2.5 milligrams of diphenoxylate and not 1,067
less than 25 micrograms of atropine sulfate per dosage unit; 1,068
(5) Not more than 100 milligrams of opium per 100 1,070
milliliters or per 100 grams; 1,071
(6) Not more than 0.5 milligram of difenoxin and not less 1,073
than 25 micrograms of atropine sulfate per dosage unit. 1,074
(C) Stimulants 1,076
Unless specifically exempted or excluded under federal drug 1,078
abuse control laws or unless listed in another schedule, any 1,079
material, compound, mixture, or preparation that contains any 1,080
quantity of the following substances having a stimulant effect on 1,081
the central nervous system, including their salts, isomers, and 1,082
salts of isomers: 1,083
(1) Ephedrine, except as provided in division (K) of 1,085
section 3719.44 of the Revised Code; 1,086
(2) Pyrovalerone. 1,088
Section 2. That existing section 3719.41 of the Revised 1,090
Code is hereby repealed. 1,091